Granules India Ltd.

NSE: GRANULES | BSE: 532482 | ISIN: INE101D01020 | Industry: Pharmaceuticals
| Mid-range Performer
536.2000 -6.25 (-1.15%)
NSE Jun 11, 2025 15:31 PM
Volume: 560.1K
 

536.20
-1.15%
GEPL Capital
Granules India is a south based, fast growing global pharmaceutical company. GIL has presence across entire pharma value chain from Active Pharmaceutical Ingredients (APIs) to Pharmaceutical Formulation Intermediaries (PFIs) to Finished Dosages (FDs). It has a strong presence in first line of defense' products such as Paracetamol, Ibuprofen and Metformin. Currently, company has eight manufacturing facilities spread over India, China & US. Company operate in 75 countries, with over 300 customers across the globe & about 60% of...
Geojit BNP Paribas increased Accumulate price target of Granules India Ltd. to 599.0 on 06 Jun, 2025.
More from Granules India Ltd.
Recommended